SevenBridge Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$631K Sell
7,587
-616
-8% -$59K 0.1% 138
2025
Q4
$826K Sell
8,203
-1,909
-19% -$185K 0.13% 126
2025
Q3
$969K Sell
10,112
-2,832
-22% -$260K 0.16% 117
2025
Q2
$1.19M Sell
12,944
-1,991
-13% -$169K 0.21% 113
2025
Q1
$1.28M Sell
14,935
-3,085
-17% -$276K 0.25% 109
2024
Q4
$1.64M Sell
18,020
-5,119
-22% -$443K 0.31% 86
2024
Q3
$2.04M Sell
23,139
-60
-0.3% -$5.05K 0.39% 70
2024
Q2
$1.87M Sell
23,199
-296
-1% -$24.3K 0.41% 68
2024
Q1
$1.92M Buy
23,495
+2,042
+10% +$174K 0.43% 65
2023
Q4
$1.77M Sell
21,453
-328
-2% -$25K 0.42% 70
2023
Q3
$1.71M Buy
21,781
+500
+2% +$41.9K 0.44% 68
2023
Q2
$1.87M Buy
21,281
+1,525
+8% +$131K 0.48% 63
2023
Q1
$1.59M Buy
19,756
+2,128
+12% +$173K 0.44% 65
2022
Q4
$1.37M Buy
17,628
+977
+6% +$79.2K 0.4% 66
2022
Q3
$1.34M Buy
16,651
+4,751
+40% +$427K 0.46% 58
2022
Q2
$1.07M Buy
11,900
+708
+6% +$71.7K 0.43% 63
2022
Q1
$1.24M Buy
11,192
+5,968
+114% +$631K 0.44% 61
2021
Q4
$540K Buy
5,224
+1,183
+29% +$137K 0.16% 108
2021
Q3
$507K Sell
4,041
-1
-0% -$129 0.17% 105
2021
Q2
$502K Buy
4,042
+237
+6% +$29.8K 0.16% 106
2021
Q1
$449K Sell
3,805
-45
-1% -$5.27K 0.16% 110
2020
Q4
$451K Buy
3,850
+735
+24% +$80.9K 0.18% 102
2020
Q3
$324K Sell
3,115
-55
-2% -$5.52K 0.15% 107
2020
Q2
$291K Sell
3,170
-77
-2% -$7.38K 0.14% 106
2020
Q1
$293K Buy
3,247
+96
+3% +$10.2K 0.17% 99
2019
Q4
$357K Hold
3,151
0.09% 115
2019
Q3
$342K Hold
3,151
0.18% 100
2019
Q2
$307K Sell
3,151
-375
-11% -$34.2K 0.11% 117
2019
Q1
$321K Buy
3,526
+199
+6% +$17.8K 0.12% 104
2018
Q4
$303K Sell
3,327
-39
-1% -$3.64K 0.19% 88
2018
Q3
$331K Buy
3,366
+410
+14% +$37.9K 0.18% 97
2018
Q2
$253K Buy
2,956
+1,119
+61% +$93.5K 0.14% 119
2018
Q1
$147K Sell
1,837
-110
-6% -$9.07K 0.08% 153
2017
Q4
$157K Sell
1,947
-250
-11% -$20K 0.09% 153
2017
Q3
$171K Buy
2,197
+950
+76% +$78.9K 0.1% 145
2017
Q2
$111K Hold
1,247
0.07% 179
2017
Q1
$100K Sell
1,247
-936
-43% -$73.1K 0.07% 175
2016
Q4
$182K Hold
2,183
0.13% 138
2016
Q3
$182K Sell
2,183
-144
-6% -$12.5K 0.13% 138
2016
Q2
$202K Buy
+2,327
New +$188K 0.14% 134

Other funds holding MDT

SevenBridge Financial Group's MDT Position: Q1 2026 in Review

SevenBridge Financial Group reduced its Medtronic (MDT) stake by 7.5% in Q1 2026, selling an estimated $59K and leaving 7,587 shares worth $631K. The position accounts for 0.1% of the portfolio, ranked #138.

SevenBridge Financial Group first reported a position in MDT in Q2 2016 and has held it in 40 quarters since. The position peaked at $2.04M in Q3 2024. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • SevenBridge Financial Group held 7,587 shares of Medtronic worth $631K as of Q1 2026.
  • SevenBridge Financial Group sold 616 Medtronic shares in Q1 2026, an estimated $59K.
  • Medtronic made up 0.1% of SevenBridge Financial Group's portfolio in Q1 2026, its #138 holding.
  • SevenBridge Financial Group first reported a position in Medtronic in Q2 2016 and has held it in 40 quarters since.
  • SevenBridge Financial Group's Medtronic position peaked at $2.04M in Q3 2024.
  • 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on SevenBridge Financial Group's 13F filing for Q1 2026, filed 23 Apr 2026.